These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34846788)

  • 21. A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma.
    Otb S; Shaarawy E; Sadek A; Abdallah N; Agamia N; Soliman M; Tawfik AA
    J Dermatolog Treat; 2022 Feb; 33(1):555-559. PubMed ID: 32420770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of effectiveness of tranexamic acid as mesotherapy in improvement of periorbital wrinkling in a trial study.
    Bazargan AS; Shemshadi M; Ziaeifar E; Taheri A; Roohaninasab M; Goodarzi A; Mirhashemi M
    J Cosmet Dermatol; 2023 Sep; 22(9):2548-2552. PubMed ID: 36987386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: A review.
    Mahjoub TT; Milibary HH
    J Cosmet Dermatol; 2023 Apr; 22(4):1157-1162. PubMed ID: 36575866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tranexamic acid: an important adjuvant in the treatment of melasma.
    Tse TW; Hui E
    J Cosmet Dermatol; 2013 Mar; 12(1):57-66. PubMed ID: 23438143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of efficacy of Tranexamic Acid Mesotherapy versus 0.9% normal Saline for Melasma; A split face study in a Tertiary Care Hospital of Karachi.
    Kaleem S; Ghafoor R; Khan S
    Pak J Med Sci; 2020; 36(5):930-934. PubMed ID: 32704266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis.
    Bailey AJM; Li HO; Tan MG; Cheng W; Dover JS
    J Am Acad Dermatol; 2022 Apr; 86(4):797-810. PubMed ID: 33857549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma.
    Gamea MM; Kamal DA; Donia AA; Hegab DS
    J Dermatolog Treat; 2022 Mar; 33(2):798-804. PubMed ID: 32567984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical 5% tranexamic acid with 30% glycolic acid peel: An useful combination for accelerating the improvement in melasma.
    Sahu P; Dayal S; Bhardwaj N
    Dermatol Ther; 2021 Nov; 34(6):e15107. PubMed ID: 34423510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of tranexamic acid versus vitamin c after microneedling in treatment of melasma: Clinical and Dermoscopic study.
    El Attar Y; Doghaim N; El Far N; El Hedody S; Hawwam SA
    J Cosmet Dermatol; 2022 Jul; 21(7):2817-2825. PubMed ID: 34699671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
    Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
    Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study.
    Tahoun AI; Mostafa WZ; Amer MA
    J Dermatolog Treat; 2022 May; 33(3):1623-1629. PubMed ID: 33393842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing the efficacy of Myjet-assisted tranexamic acid and vitamin C in treating melasma: A split-face controlled trial.
    Zhao H; Li M; Zhang X; Li L; Yan Y; Wang B
    J Cosmet Dermatol; 2020 Jan; 19(1):47-54. PubMed ID: 31479196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis.
    Lee HC; Thng TG; Goh CL
    J Am Acad Dermatol; 2016 Aug; 75(2):385-92. PubMed ID: 27206758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
    Park SJ; Park JW; Seo SJ; Park KY
    Dermatol Ther; 2022 Mar; 35(3):e15287. PubMed ID: 34962047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.
    Kim HJ; Moon SH; Cho SH; Lee JD; Kim HS
    Acta Derm Venereol; 2017 Jul; 97(7):776-781. PubMed ID: 28374042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
    El Hadidi H; Mosaad R; Ragab N
    Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.